Kaplan Fox & Kilsheimer LLP Reminds Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline Kaplan Fox alerts investors of class action and upcoming deadline.

Lowey Dannenberg, P.C. is Investigating Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) for Potential Violations of the Federal Securities Laws NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Eagle Pharmaceuticals, Inc. (“Eagle” or...